MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

229.66 -6.23 (-2.64%)
Streaming Delayed Price Updated: 2:50 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Discover which S&P500 stocks are making waves on Thursday. ↗
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
News headline image
West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand ↗
West Pharmaceutical posts Q3 earnings of $1.96 per share and raises 2025 guidance, driven by GLP-1 demand and strong HVP component growth. 
Via Benzinga
News headline image
These S&P500 stocks are gapping in today's session ↗
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Thursday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
News headline image
Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
Topics Stocks
News headline image
Earnings Scheduled For October 23, 2025 ↗
 
Via Benzinga
News headline image
Wondering what's happening in today's S&P500 pre-market session? ↗
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
West Pharmaceutical Services (NYSE:WST) Q3 2025 Earnings Top Estimates, Boosts Full-Year Outlook ↗
West Pharmaceutical Services (WST) beats Q3 2025 earnings and revenue estimates, raises full-year guidance. The strong results, led by an EPS beat, sent the stock up over 6% pre-market. 
Via Chartmill
News headline image
West Pharmaceutical Services’s (NYSE:WST) Q3 Sales Beat Estimates
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $804.6 million. The... 
Via StockStory
Topics Earnings Economy
News headline image
West Pharmaceutical Servs's Earnings Outlook ↗
 
Via Benzinga
News headline image
West Pharmaceutical Services (WST) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings this Thursday morning. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Cash-Producing Stocks That Fall Short
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Topics Economy
News headline image
1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Turn Down
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Topics Economy
News headline image
3 Healthcare Stocks We Keep Off Our Radar
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the... 
Via StockStory
Topics Economy Stocks
News headline image
WEST PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
News headline image
Deep Dive Into West Pharmaceutical Servs Stock: Analyst Perspectives (5 Ratings) ↗
 
Via Benzinga
News headline image
3 Reasons to Avoid WST and 1 Stock to Buy Instead
West Pharmaceutical Services has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 16.3% to $260.31 per share while the... 
Via StockStory
Topics Stocks
News headline image
Bill Gates Bets Big on Buffett: A Defensive Play Amidst Tech Uncertainty?
In a significant shift that has caught the attention of financial markets and online communities alike, Bill Gates, through his investment vehicle Cascade Investment, has made notable adjustments to... 
Via MarketMinute
Topics Economy
News headline image
Looking Into West Pharmaceutical Servs's Recent Short Interest ↗
West Pharmaceutical Servs's (NYSE: WST) short interest as a percent of float has risen 9.25% since its last report. According to exchange reported data, there are now 1.68 million shares sold short,... 
Via Benzinga
News headline image
West Pharmaceutical Services (WST) Stock Is Up, What You Need To Know
Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 3.1% in the afternoon session after a research note from KeyBanc Capital Markets indicated positive momentum in the... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Top S&P500 movers in Wednesday's session ↗
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Life Sciences Tools & Services Stocks Q2 Teardown: PacBio (NASDAQ:PACB) Vs The Rest
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the life sciences tools & services industry, including PacBio (NASDAQ:PACB) and its... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
1 Cash-Heavy Stock Worth Your Attention and 2 We Question
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining... 
Via StockStory
Topics Economy
News headline image
3 Mid-Cap Stocks That Concern Us
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Topics Economy
News headline image
Life Sciences Tools & Services Stocks Q2 Results: Benchmarking Illumina (NASDAQ:ILMN)
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the life sciences tools & services industry, including Illumina (NASDAQ:ILMN) and its... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
1 S&P 500 Stock on Our Watchlist and 2 Facing Challenges
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Economy Stocks
News headline image
Q2 Earnings Highs And Lows: 10x Genomics (NASDAQ:TXG) Vs The Rest Of The Life Sciences Tools & Services Stocks
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Q2 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
Topics Economy
News headline image
What's going on in today's session: S&P500 movers ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 We Brush Off
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Topics Economy Electric Vehicles
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story